Micron Biomedical
Atlanta-based Micron Biomedical, Inc. specializes in commercial physical and biological R&D since 2012.
Founded
2014Atlanta-based Micron Biomedical, Inc. specializes in commercial physical and biological R&D since 2012.
Founded in 2012 and based in Atlanta, Micron Biomedical, Inc. focuses on commercial physical and biological research and development. The company's core mission is to revolutionize the delivery of vaccines and therapeutics through needle-free, thermostable technology, making medicine more accessible and user-friendly. Their innovative products aim to provide effective and convenient healthcare solutions that can be administered anytime and anywhere, addressing critical needs in both developed and developing regions.
Micron Biomedical has garnered attention for its pioneering approach to drug delivery, attracting notable investors and partnerships within the biotech industry. The company's achievements include successful clinical trials and collaborations with leading healthcare organizations. Their impact lies in enhancing global health by providing safer, more efficient methods for vaccine and therapeutic administration, potentially transforming the way medical treatments are delivered worldwide.
Companies similar to Micron Biomedical include TheraJect, Piezo Therapeutics, SingleTimeMicroneedles and SeeTrue Technology.
Micron Biomedical was founded in 2014.
Micron Biomedical's headquarters is located in Atlanta, GA, US.
Micron Biomedical's most recent funding round was for $23.6M (USD) in November 2023.
As of Nov 16, 2023, Micron Biomedical has disclosed funding of $40.6M (USD). Undisclosed round amounts are excluded.
Micron Biomedical has 13 employees as of Feb 5, 2024.
SeeTrue Technology
